Yoshikawa, Hideki
Toyonaka Municipal Hospital,
Japan
2025 Rank: 91,955
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Orthopedics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 462 out of 91,178 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91,955 | 96,493 |
| Total Cites | 1,790 | 1,997 |
| H-index | 14 | 14 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 44 | 44 |
| Number of Single+First+Last Authored Papers | 423 | 423 |
| Total Cites to Single+First+Last Authored Papers | 793 | 857 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,559 | 1,637 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.22 |
| Self-Citation Percentage |
10.37%
|
|
Yoshikawa, Hideki
Toyonaka Municipal Hospital,
Japan
2024 Rank: 83,964
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Orthopedics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 408 out of 83,175 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83,964 | 90,304 |
| Total Cites | 1,815 | 1,967 |
| H-index | 14 | 14 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 41 | 41 |
| Number of Single+First+Last Authored Papers | 423 | 423 |
| Total Cites to Single+First+Last Authored Papers | 783 | 830 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,602 | 1,671 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.18 |
| Self-Citation Percentage |
7.73%
|
|
Yoshikawa, Hideki
Toyonaka Municipal Hospital,
Japan
2023 Rank: 63,433
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Orthopedics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 328 out of 77,248 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 63,433 | 68,973 |
| Total Cites | 2,119 | 2,312 |
| H-index | 15 | 16 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 58 | 58 |
| Number of Single+First+Last Authored Papers | 422 | 422 |
| Total Cites to Single+First+Last Authored Papers | 895 | 946 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,842 | 1,927 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.20 |
| Self-Citation Percentage |
8.35%
|
|
Yoshikawa, Hideki
Toyonaka Municipal Hospital,
Japan
2022 Rank: 68,310
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Orthopedics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 365 out of 71,530 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68,310 | 72,894 |
| Total Cites | 2,113 | 2,387 |
| H-index | 14 | 15 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 38 | 39 |
| Number of Single+First+Last Authored Papers | 421 | 421 |
| Total Cites to Single+First+Last Authored Papers | 909 | 993 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,869 | 1,967 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.21 |
| Self-Citation Percentage |
11.48%
|
|
Yoshikawa, Hideki
Graduate School of Medicine,
Japan
2021 Rank: 61,830
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Orthopedics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 349 out of 67,782 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61,830 | 62,395 |
| Total Cites | 3,202 | 3,614 |
| H-index | 21 | 22 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 63 | 66 |
| Number of Single+First+Last Authored Papers | 418 | 418 |
| Total Cites to Single+First+Last Authored Papers | 1,334 | 1,473 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,790 | 2,954 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.22 |
| Self-Citation Percentage |
11.40%
|
|
Yoshikawa, Hideki
Osaka University Faculty of Medicine,
Japan
2020 Rank: 56,265
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Orthopedics
SubField 2:
Arthritis & Rheumatology
Rank in SubField 1: 290 out of 57,183 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56,265 | 60,091 |
| Total Cites | 2,346 | 2,629 |
| H-index | 17 | 18 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 63 | 63 |
| Number of Single+First+Last Authored Papers | 405 | 405 |
| Total Cites to Single+First+Last Authored Papers | 994 | 1,089 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 2,025 | 2,148 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.22 |
| Self-Citation Percentage |
10.76%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.